Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

Jun Liu; Yang Yang; Zhichao Liu; Xiaolong Fu; Xiaoyue Cai; Hongxuan Li; Li Zhu; Yan Shen; Hong Zhang; Yifeng Sun

doi:10.1136/jitc-2021-004291

Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

Identifier:nobleid.org/w1/20260526/1E1ACDF0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1E1ACDF0.svg?ark=w1%2F20260526%2F1E1ACDF0)](https://nobleid.org/work/w1/20260526/1E1ACDF0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

Identifier:nobleid.org/w1/20260526/1E1ACDF0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1E1ACDF0.svg?ark=w1%2F20260526%2F1E1ACDF0)](https://nobleid.org/work/w1/20260526/1E1ACDF0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work